during the quickly evolving field of oncology study, accurate and successful mutation screening is very important for establishing specific therapies. The KRAS solutions System performs a pivotal function With this landscape by providing complete options for KRAS mutation profiling and Investigation. KRAS mutations, found in close to 95% of RAS-rel